| Date Filed | Type | Description |
| 06/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/01/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2020 |
SC 13D
| Evans Daron reports a 5.1% stake in NEPHROS, INC. |
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 97,076 options to buy
@ $5.4, valued at
$524.2k
|
|
| 12/18/2019 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 9,282 shares
@ $0
Granted 20,000 options to buy
@ $8.57, valued at
$171.4k
|
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/22/2019 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 2,000 shares
@ $6.9227, valued at
$13.8k
|
|
| 08/13/2019 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 36,404 options to buy
@ $5.4, valued at
$196.6k
|
|
| 06/14/2019 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 11,172 shares
@ $0.5982, valued at
$6.7k
Bought 8,000 shares
@ $0.5816, valued at
$4.7k
Bought 8,000 shares
@ $0.59, valued at
$4.7k
Bought 8,000 shares
@ $0.6094, valued at
$4.9k
Bought 8,000 shares
@ $0.6037, valued at
$4.8k
|
|
| 12/18/2018 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 108,296 shares
@ $0 |
|
| 05/14/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2018 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 55,000 shares
@ $0.45, valued at
$24.8k
Bought 12,000 shares
@ $0.45, valued at
$5.4k
|
|
| 02/22/2018 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 218,419 options to buy
@ $0.6, valued at
$131.1k
|
|
| 01/04/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/22/2017 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 180,000 shares
@ $0
Granted 837,125 options to buy
@ $0.4999, valued at
$418.5k
|
|
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2017 |
SC 13G
| Viking Therapeutics, Inc. has filed a Schedule 13D for Viking Therapeutics, Inc. |
| 12/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2016 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 9,165 shares
@ $0 |
|
| 12/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/18/2015 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 42,840 shares
@ $0 |
|
| 09/11/2015 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Granted 70,610 shares
@ $0 |
|
| 08/31/2015 |
4
| Evans Daron (President and CEO) has filed a Form 4 on NEPHROS INC|
Txns:
| Bought 19,175 shares
@ $0.56, valued at
$10.7k
Bought 5,000 shares
@ $0.58, valued at
$2.9k
Bought 10,000 shares
@ $0.6, valued at
$6k
Bought 10,000 shares
@ $0.57, valued at
$5.7k
|
|
|